[SCHEDULE 13G/A] Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares SEC Filing

Rhea-AI Filing Summary

Allspring Global Investments Holdings, LLC has filed Amendment No. 7 to Schedule 13G declaring its current ownership in Zepp Health Corp (symbol ZEPP) as of 30 June 2025.

• Shares owned: 9,757,152 American Depositary Receipts (ADRs).
• Ownership percentage: 8.7 % of the outstanding ADR class, exceeding the 5 % reporting threshold.
• Voting/dispositive power: Sole voting power and sole dispositive power over the entire position; no shared power reported.
• Holder classification: Designated as a Holding Company/Control person (Item 3 — HC).
• Stake origin: Securities are held for clients of subsidiaries Allspring Global Investments, LLC and Allspring Funds Management, LLC; no single client holds more than 5 % of the class.
• Intent statement: Filing certifies the position was acquired in the ordinary course of business and not to influence control of Zepp Health.
• Signatories & dates: Event date 06-30-2025; filing signed by Senior Compliance Manager Jennifer Grunberg on 07-14-2025.

This disclosure signals a sizeable passive institutional position in Zepp Health, potentially viewed by the market as a vote of confidence in the company’s prospects without implying activist intentions.

Positive

• Institutional ownership of 8.7 % indicates strong passive confidence from Allspring, enhancing ZEPP’s shareholder base and liquidity.
• Sole voting and dispositive power provide Allspring clear decision authority on its shares, reducing complexity around potential vote splits.

Negative

• None.

Insights

Financial Analyst

TL;DR: Allspring’s 8.7 % passive stake reveals material institutional support for ZEPP.

Allspring’s sole-controlled holding of 9.76 million ADRs places it among Zepp Health’s largest shareholders. The absence of shared voting/dispositive power and the ordinary-course certification indicate a non-activist, portfolio-allocation motive. Still, surpassing the 5 % threshold gives Allspring influence over shareholder votes and reflects confidence in Zepp’s valuation. For investors, the filing removes uncertainty around ownership concentration and points to a deeper institutional investor base, which can improve liquidity and potentially reduce volatility.

Portfolio Manager

TL;DR: Passive 13G suggests no control agenda, but a meaningful anchor investor for ZEPP.

An 8.7 % position is significant for any sub-$1 billion market-cap issuer. While purely passive, Allspring’s vote can sway key resolutions, especially given historically low turnout in ADR-listed Chinese equities. For existing shareholders, the visibility of a notable U.S. asset manager may broaden analyst coverage and attract similar funds. No immediate dilution or governance change is implied, so the impact skews modestly positive.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

Zepp Health Corp

(Name of Issuer)

Depositary Receipt ADR

(Title of Class of Securities)

98945L204

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 98945L204

1

Names of Reporting Persons

Allspring Global Investments Holdings, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 9,757,152.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 9,757,152.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,757,152.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.7 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Zepp Health Corp
(b)	Address of issuer's principal executive offices: BUILDING B2, ZHONG'AN CHUANGGU, TECHNOLOGY PARK NO.900 WANGJIANG WEST RD, HEFEI, China, 230088
Item 2.
(a)	Name of person filing: Allspring Global Investments Holdings, LLC
(b)	Address or principal business office or, if none, residence: 1415 Vantage Park Drive, Charlotte, 28203, North Carolina, United States
(c)	Citizenship: DELAWARE
(d)	Title of class of securities: Depositary Receipt ADR
(e)	CUSIP No.: 98945L204
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 9,757,152
(b)	Percent of class: 8.7 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 9,757,152
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 9,757,152
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The securities as to which this Schedule is filed are owned of record by clients of one or more Investment Advisers identified in Exhibit A directly or indirectly owned by Allspring Global Investments Holdings, LLC. Those Clients have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds for the sale of, such securities. No such client is known to have such right or power with respect to more than five percent of this class of securities, except as follows: None
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit A
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Allspring Global Investments Holdings, LLC

Signature:	Jennifer Grunberg
Name/Title:	Senior Compliance Manager
Date:	07/14/2025

Exhibit Information

Exhibit A Subsidiary Allspring Global Investments, LLC* - IA Allspring Funds Management, LLC* - IA *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this schedule 13G.

FAQ

What percentage of Zepp Health (ZEPP) does Allspring Global Investments own?

The Schedule 13G reports Allspring beneficially owns 8.7 % of Zepp Health’s ADRs.

How many Zepp Health ADRs are held by Allspring according to the filing?

Allspring discloses ownership of 9,757,152 ADRs.

Does Allspring share voting power over its ZEPP stake?

No. The firm reports sole voting and dispositive power over all 9.76 million ADRs.

Why did Allspring file Amendment No. 7 to Schedule 13G for Zepp Health?

Because its ownership exceeded the 5 % threshold (now 8.7 %), requiring an updated disclosure under SEC rules.

When were the event and filing dates for Allspring’s Schedule 13G?

Event date: 06/30/2025; signature date: 07/14/2025.

Which Allspring subsidiaries are linked to the ZEPP holdings?

The ADRs are held for clients of Allspring Global Investments, LLC and Allspring Funds Management, LLC.

How is Allspring classified in the filing?

It is classified as a Holding Company/Control Person (HC) under Rule 13d-1(b)(1)(ii)(G).